Literature DB >> 9751252

Protein turnover in skeletal muscle of tumour-bearing transgenic mice overexpressing the soluble TNF receptor-1.

M Llovera1, C García-Martínez, J López-Soriano, N Agell, F J López-Soriano, I Garcia, J M Argilés.   

Abstract

The implantation of the Lewis lung carcinoma (a fast-growing mouse tumour that induces cachexia) to both wild-type and transgenic mice for the soluble TNF receptor type I protein (sTNF-R1) resulted in a considerable loss of carcass weight in both groups. However, while in the wild-type mice there was a loss of both fat and muscle, in the transgenic mice muscle waste was not affected to the same extent as in the wild-type group. Muscle waste in wild-type mice was accompanied by an increase in the fractional rate of protein degradation, while no changes were observed in protein synthesis. The result was a decreased rate of protein accumulation which accounted for the muscle weight loss observed as a result of the tumour burden. In contrast, transgenic mice did not have such low rates of protein accumulation after tumour implantation. The increase in protein degradation in the tumour-bearing transgenic mice was accompanied by a similar increase in protein synthesis which compensated for the loss of muscle protein by degradation. Both tumour-bearing groups showed an enhanced expression of ubiquitin and proteasome C8 subunit genes, all of them related to the activation of the ATP-dependent proteolytic system in skeletal muscle. It is suggested that TNF may, in part, be responsible for the loss of protein in skeletal muscle of tumour-bearing mice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9751252     DOI: 10.1016/s0304-3835(98)00137-2

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  25 in total

1.  Nutritional treatment of cancer cachexia in rats. Use of a diet formulated with a crayfish enzymatic extract.

Authors:  Olga Cremades; Juan Parrado; María Jover; Laura Collantes de Terán; Juan Francisco Gutiérrez; Juan D Bautista Palomas
Journal:  Eur J Nutr       Date:  2007-08-04       Impact factor: 5.614

Review 2.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

3.  Effects of conditioned media from murine lung cancer cells and human tumor cells on cultured myotubes.

Authors:  Blas A Guigni; Jos van der Velden; C Matthew Kinsey; James A Carson; Michael J Toth
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-11-05       Impact factor: 4.310

4.  Carboxyamidotriazole alleviates muscle atrophy in tumor-bearing mice by inhibiting NF-κB and activating SIRT1.

Authors:  Chen Chen; Rui Ju; Lei Zhu; Juan Li; Wei Chen; De-Chang Zhang; Cai-Ying Ye; Lei Guo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-01-25       Impact factor: 3.000

Review 5.  Animal models of the cancer anorexia-cachexia syndrome.

Authors:  Nabila Bennani-Baiti; Declan Walsh
Journal:  Support Care Cancer       Date:  2010-08-17       Impact factor: 3.603

6.  Perioperative assessment of muscle inflammation susceptibility in patients with end-stage osteoarthritis.

Authors:  Devin J Drummer; Jeremy S McAdam; Regina Seay; Inmaculada Aban; Kaleen M Lavin; Derek Wiggins; Gabriel Touliatos; Sufen Yang; Christian Kelley; S Craig Tuggle; Brandon Peoples; Herrick Siegel; Elie Ghanem; Jasvinder A Singh; Scott Schutzler; C Lowry Barnes; Arny A Ferrando; S Louis Bridges; Marcas M Bamman
Journal:  J Appl Physiol (1985)       Date:  2022-03-03

7.  Vascular endothelial growth factor-A and changes in a tumor-bearing mouse model with Lewis lung cancer.

Authors:  Meng-Shu Tsai; Cheng-Chi Chang; Min-Liang Kuo; Ying-Tai Wu
Journal:  Oncol Lett       Date:  2011-08-09       Impact factor: 2.967

Review 8.  F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities.

Authors:  Ammar Sukari; Irfana Muqbil; Ramzi M Mohammad; Philip A Philip; Asfar S Azmi
Journal:  Semin Cancer Biol       Date:  2016-01-21       Impact factor: 15.707

Review 9.  Exosomal microRNAs in cancer-related sarcopenia: Tumor-derived exosomal microRNAs in muscle atrophy.

Authors:  Chenyuan Li; Qi Wu; Zhiyu Li; Zhong Wang; Yi Tu; Chuang Chen; Si Sun; Shengrong Sun
Journal:  Exp Biol Med (Maywood)       Date:  2021-02-07

10.  Molecular and cellular mechanisms of skeletal muscle atrophy: an update.

Authors:  Alessandro Fanzani; Viviane M Conraads; Fabio Penna; Wim Martinet
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-06-07       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.